Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT01616056
Brief Summary:
This phase II clinical trial studies how well bandage lenses work in treating patients with ocular graft versus host disease. Bandage lenses may be helpful in relieving eye symptoms and damage caused by eye graft versus host disease.
Detailed Description:
PRIMARY OBJECTIVES:
I. To determine the symptom improvement after 2 weeks of therapy with bandage lenses.
SECONDARY OBJECTIVES:
I. To confirm short-term safety within 1 month after bandage lenses.
II. To determine improvement in ophthalmologic examinations after bandage lenses.
III. To explore the use of optical coherence tomography as an objective measure of corneal inflammation.
OUTLINE:
Patients wear bandage lenses continuously for at least 3 months in the absence of disease progression or unacceptable toxicity.
Study:
NCT01616056
Study Brief:
Protocol Section:
NCT01616056